Aug 21,2017

Fruit Street to deliver CDC's National Diabetes Prevention Program through live video classes

Fruit Street Health, a New York City-based telemedicine company, says it's the first organization to be recognized by the Centers for Disease Control and Prevention to deliver its National Diabetes Prevention Program through classes delivered by live video feed.

PRODUCT

#mobile app

#telehealth

View Analyst & Ambassador Comments
Go to original news
Aug 01,2017

Insulet Corporation to Present at Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at three upcoming investor conferences in New York City, New York: The 2017 Wedbush PacGrow Healthcare Conference, The Baird 2017 Global Healthcare Conference & The Morgan Stanley Global Healthcare Conference.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 01,2017

Nemaura Develops Rechargeable Transmitter for sugarBEAT®

Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, announced today that it has developed a slimmer sugarBEAT® transmitter with a built in rechargeable battery. This new format is expected to lower costs for users given it removes the need for disposable batteries.

PRODUCT

#cgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 01,2017

CGM study: Glucose-lowering effect of whey protein depends upon clinical characteristics of patients with type 2 diabetes

This is the first study to investigate glucose response to Whey protein (WP) using continuous glucose monitoring (CGM) over several days. Glucose response to WP was found to be variable but predictable. Lower body mass index, triglyceride and glucagon-like peptide (GLP)-1 predicted glucose lowering, whereas obesity, hypertriglyceridemia and high fasting GLP-1 concentrations predicted increased glucose response to WP.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Aug 01,2017

Tandem Diabetes Care to Present at the 2017 Wedbush PacGrow Healthcare Conference

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that Kim Blickenstaff, president and CEO, will present a company update at the 2017 Wedbush PacGrow Healthcare Conference in New York, NY. The presentation will take place on Tuesday, August 15, 2017 at 1:20 PM Eastern Time (10:20 AM Pacific Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 01,2017

Senseonics Holdings, Inc. Schedules Second Quarter 2017 Earnings Release and Conference Call for August 9, 2017 at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE-MKT:SENS), a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that it plans to release its second quarter 2017 financial results after market close on Wednesday, August 9, 2017.

View Analyst & Ambassador Comments
Go to original news
Aug 02,2017

Senseonics to Present at the Canaccord Genuity Growth Conference

Senseonics Holdings Inc. (NYSE-MKT: SENS), a medical technology company focused on the development and commercialization of transformative glucose monitoring products, today announced the company plans to participate in the 37th Annual Growth Conference hosted by Canaccord Genuity in Boston, MA. Senseonics’ management is scheduled to present on Thursday, August 10, 2017 at 1:00pm ET.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 02,2017

Insulet's Programs at the American Association of Diabetes Educators Conference and Its New San Diego Innovation Center of Excellence Highlight Company's Commitment to Innovation

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced several educational programs to help health care providers better connect with and treat their patients living with diabetes. Insulet will exhibit at the 2017 American Association of Diabetes Educators (AADE) Conference in Indianapolis, Indiana from August 3rd to August 5th.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 03,2017

Nemaura Appoints Thomas Moore to Board of Directors as Independent Director

Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, announced today that it has appointed Thomas Moore to the company’s Board of Directors. Mr. Moore will serve as an independent director of the company, and as member of the board’s Audit, Nominating and Corporate Governance and Compensation Committees.

View Analyst & Ambassador Comments
Go to original news
Aug 03,2017

Former CMS Head Dr. Don Berwick Joins Virta Health Board of Directors

Virta Health, an online specialty medical clinic that reverses type 2 diabetes safely and sustainably, announced today that former Centers for Medicare & Medicaid Services Administrator Dr. Don Berwick is joining its Board of Directors. Drawing on decades of research, including that of its founders, Virta’s approach to type 2 diabetes reversal puts physicians and coaches into the pockets of patients through their smartphones to support everyday decisions, minute by minute.

View Analyst & Ambassador Comments
Go to original news